4.4 Article

Epidemiology of Vasomotor Rhinitis

期刊

WORLD ALLERGY ORGANIZATION JOURNAL
卷 2, 期 -, 页码 115-118

出版社

BIOMED CENTRAL LTD
DOI: 10.1097/WOX.0b013e3181ac91ae

关键词

vasomotor rhinitis; epidemiology; nonallergic rhinopathy; nonallergic rhinitis

资金

  1. GlaxoSmithKline (GSK)
  2. Sanofi-Aventis Pharmaceuticals
  3. Meda Pharmaceuticals
  4. Alcon Laboratories
  5. TREAT Foundation (Washington, DC)

向作者/读者索取更多资源

Vasomotor rhinitis is the most common form of nonallergic rhinitis, comprising approximately 71% of all nonallergic rhinitis conditions. Although the epidemiology of this subtype of nonallergic rhinitis has not been definitively studied, it is estimated that 14 million Americans suffer from vasomotor rhinitis, with a worldwide prevalence approaching 320 million.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据